Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2010-03-02

Clinical Trial Update: Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating sildenafil's effect on endothelial function in sickle cell disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: The Baruch Padeh Medical Center, Poriya | Conditions: Sickle Cell Anemia | Phase 4 | Status: WITHDRAWN